Unless otherwise indicated, faculty members and moderators have disclosed no relevant financial relationships. ACOI staff members, activity planners, & CME Committee members have disclosed no relevant financial relationships.

The following faculty have disclosed financial relationships, and all relevant financial relationships were mitigated:

2025 Internal Medicine Comprehensive Update

Joel Abbott, DO – Boston Scientific - Consulting fee – Consultant; Karl Storz – Consulting Fee - Consultant

Chad Link, DO, FACOI - Astra Zeneca - Consulting fee – Consultant; Johnson and Johnson - Consulting fee – Consultant; Kiniska - Consulting fee – Consultant

Jack L. Snitzer, DO, FACOI - Dexcom - Consulting fee – Consultant  

David Strobl, DO - Amarin - Consulting fee – Consultant, Amgen - Consulting fee – Consultant 

2025 Clinical Challenges in Hospital Medicine

Jeffrey Freeman – Bayer Pharm - Consulting fee – Consultant; Mankind - Consulting fee – Consultant; Novo Nordisk - Consulting fee – Consultant

Chad Link - Astra Zeneca - Consulting fee – Consultant; Johnson and Johnson - Consulting fee – Consultant; Kiniska - Consulting fee – Consultant